Halbert Hargrove Global Advisors, LLC Natera, Inc. Transaction History

Halbert Hargrove Global Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$30.32 - $91.33 $198,110 - $596,750	-6,534 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $776 - $1,071	-9 Reduced 0.14%	6,534 $610,000
Q3 2021 Oct 29, 2021	SELL	$100.17 - $126.36 $250,324 - $315,773	-2,499 Reduced 27.64%	6,543 $729,000
Q2 2021 Jul 29, 2021	BUY	$86.05 - $119.72 $1,376 - $1,915	16 Added 0.18%	9,042 $1.03 Million
Q1 2021 May 06, 2021	BUY	$91.47 - $124.36 $825,608 - $1.12 Million	9,026 New	9,026 $916,000

504

120M

412K

270K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $12.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.